A Case of Candida Bursitis Associated with Etanercept Treatment in a Patient with Rheumatoid Arthritis.
10.4078/jkra.2008.15.2.175
- Author:
Kwang Sun LEE
1
;
Ha Yeon LEE
;
Sang Won LEE
;
Ho Joong JUNG
;
Jung Soo SONG
Author Information
1. Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. drsong@cau.ac.kr
- Publication Type:Case Report
- Keywords:
Etanercept;
Candida parapsilosis;
Bursitis;
Rheumatoid arthritis
- MeSH:
Female;
Humans;
Tumor Necrosis Factor-alpha
- From:The Journal of the Korean Rheumatism Association
2008;15(2):175-179
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Tumor necrosis factor (TNF)-alpha blockade has been well proved to significantly improve the disease course of rheumatoid arthritis. However, since TNF-alpha plays an important role in the immune system against external infectious organisms, it was reported that TNF-alpha blockade could increase the frequency of serious opportunistic infections such as tuberculosis. Fungal bursitis is a rare infectious disease following sever infections, malignancies and immune deficiencies. Moreover, there was no report on fungal bursitis occurring after administration of TNF-alpha blockade in Korea to date. Recently we experienced a 58-year-old female patient with rheumatoid arthritis who presented soft buttock mass after treatment with etanercept and was finally diagnosed as fungal bursitis by Candida parapsilosis.
